Stimcell Energetics (STME) Common Equity (2011 - 2026)
Stimcell Energetics' (STME) quarterly Common Equity came in at -$1.7 million in Q1 2026, down 56.83% year-on-year from -$3.9 million in Q1 2025, and down 8.83% quarter-over-quarter from -$1.5 million in Q4 2025.
Stimcell Energetics (STME) Common Equity (2011 - 2026) Analysis & Trends
Stimcell Energetics' Common Equity history runs 15 years deep, the most recent figure standing at -$1.7 million for Q1 2026.
- On a quarterly basis, Common Equity fell 56.83% year-over-year to -$1.7 million in Q1 2026; TTM through Feb 2026 was -$1.7 million, a 56.83% decrease from a year earlier, with the FY2025 full-year figure at -$1.2 million, down 50.8% from the prior year.
- Common Equity slipped to -$1.7 million in Q1 2026 per STME's latest filing, from -$1.5 million in the prior quarter.
- Across five years, Common Equity topped out at -$709946.0 in Q1 2024 and bottomed at -$2.5 million in Q4 2023.
- The 5-year median for Common Equity is -$1.7 million (2026), against an average of -$1.7 million.
- Across the five-year window, Common Equity soared 69.2% in 2024 and slumped 56.94% in 2025, its largest moves.
- Year by year, Common Equity stood at -$2.2 million in 2022, then decreased by 14.83% to -$2.5 million in 2023, then jumped by 61.09% to -$982705.0 in 2024, then sank by 56.94% to -$1.5 million in 2025, then dropped by 8.83% to -$1.7 million in 2026.
- Per Business Quant, the three latest STME Common Equity figures stand at -$1.7 million (Q1 2026), -$1.5 million (Q4 2025), and -$1.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 52.70 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 38.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 50.07 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 25.86 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 10.33 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.96 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 13.34 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.67 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 5.29 Bn |
| 10 | Stimcell Energetics | 5.85 Mn | 5.84 Mn | - | -1.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -1.68 Mn |
| Nov 30, 2025 | -1.54 Mn |
| Aug 31, 2025 | -1.39 Mn |
| May 31, 2025 | -1.25 Mn |
| Feb 28, 2025 | -1.07 Mn |
| Nov 30, 2024 | -982,705.00 |
| Aug 31, 2024 | -908,730.00 |
| May 31, 2024 | -826,455.00 |
| Feb 29, 2024 | -709,946.00 |
| Nov 30, 2023 | -2.53 Mn |
| Aug 31, 2023 | -2.47 Mn |
| May 31, 2023 | -2.39 Mn |
| Feb 28, 2023 | -2.30 Mn |
| Nov 30, 2022 | -2.20 Mn |
| Aug 31, 2022 | -2.10 Mn |
| May 31, 2022 | -2.01 Mn |
| Feb 28, 2022 | -1.84 Mn |
| Nov 30, 2021 | -1.71 Mn |
| Aug 31, 2021 | -1.55 Mn |
| May 31, 2021 | -1.58 Mn |